Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand

Amsterdam (ots/PRNewswire) -

CPhI announces that CPhI and P-MEC India, run by leading events
organiser UBM, is returning to the Bombay Convention and Exhibition
Centre, Mumbai (India) from the 3rd to the 5th December 2013. The
event will return with an increased scale, continuing its commitment
to cater to all sectors of the pharma industry by co-locating with
ICSE and BioPh India.

(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

With a view to enhancing the customer experience and ROI value,
CPhI India has enhanced the mobile application, now available on all
mobile devices with an internet connection, designed to help
attendees navigate their way around the event, drive traffic to
stands and stay up to date with schedules and speaker events.

With the addition of hall 7, P-MEC will host even more exhibitors
than previous years. Last year, there were 926 exhibitors present and
this is expected to rise to 1,000 this year to create the biggest
show to date. Free online registration to attend CPhI and P-MEC India
is now closed, however registration is still possible in Mumbai, the
onsite fee is only INR500.

India has increasingly become a focal point of the pharmaceutical
industry and is now the third largest in terms of volume. The country
is fast becoming an innovation hub, increasingly matching Western
standards, whilst also reducing the costs of manufacturing,
showcasing the Indian pharma markets unique position and providing an
optimum investment platform for international companies. Outside of
the US, India has the highest number of FDA approved facilities
(546), and the Indian pharma sector received USFDA approvals for
around 40% of all Abbreviated New Drug Approvals (ANDA) during
January-July 2013. Further, with R&D investments rapidly advancing,
coupled with the rise in generics and supergenerics, India represents
a key maturing market, with CPhI and P-MEC India facilitating
opportunities to drive and enhance the sector.

Ahead of the event, the UBM India pharma awards will take place on
2nd December, celebrating the most innovative and dynamic areas
across the Indian pharma community. Honouring companies who are
driving forward industry changing initiatives, there will be awards
for multiple categories including 'Excellence in Product
Development', 'Excellence in Contract Research' and 'Excellence in
Packaging Development'. The evening will also host a panel discussion
on 'Moving up the Global Pharma Value Chain', designed to inform and
educate those present at the awards ceremony.

"The global pharmaceutical market has seen a significant shift
over the last year, particularly as patent expirations are becoming
more frequent and a potential patent cliff is shaking the industry.
India, however, is thriving as the demand for generics is on the rise
and companies are looking to drive down manufacturing costs. India is
well positioned to accommodate increased demand, providing expertise
in development and manufacturing. CPhI and P-MECIndia will provide
the ideal and essential platform for international and domestic
suppliers and buyers to break into the market." - Chris Kilbee, Group
Director, Pharma.

Notes to editors

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. CPhI hosts events in Europe, China, India, Japan, Southeast
Asia, Russia and South America co-located with ICSE for contract
services, P-MEC for machinery, equipment & technology, InnoPack for
pharmaceutical packaging and BioPh for biopharma. CPhI provides an
online buyer & supplier directory at CPhI-Online.com and hosts a
global community with news and analysis at PharmaEvolution.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also
includes CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan ; CPhI Russia
and IPhEB (16-17 April, 2014 in St Petersburg, Russia); CPhI, P-MEC
and Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia);
CPhI Istanbul (4-6 June, 2014, Turkey) and CPhI, Hi and Fi, ICSE,
P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC, Shanghai,
China), CPhI South America (5-7 August 2014 at Expo Centre Norte, Sao
Paulo - Brazil); CPhI Worldwide, ICSE, P-MEC Europe and InnoPack

For media enquiries, please contact:

Alex Heeley or Tristan Jervis
De Facto Communications
T: +44(0)207-203-6745
E: a.heeley@defacto.com, t.jervis@defacto.com

Photo:
http://photos.prnewswire.com/prnh/20130723/629764-a

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de